Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep22 | Adrenal cortex (to include Cushing's) | ECE2017

Cardiovascular risk factors do not play a role in the risk factor profile of adrenal crisis

Quinkler Marcus , Murray Robert D. , Zhang Pinggao , Zelissen Pierre , Ekman Bertil

Introduction: Adrenal crises (ACs) are life-threatening events in patients with primary (PAI) or secondary (SAI) adrenal insufficiency, occurring ~4–10 times per 100 patient-years. Major causes of ACs are infections, especially gastroenteritis and tonsillitis/laryngitis. Risk factors for ACs remain ill defined, but could include concomitant endocrine diseases (diabetes mellitus, premature ovarian failure) in PAI, diabetes insipidus in SAI, and concomitant non-endocrine di...

ea0044p133 | Neoplasia, cancer and late effects | SFEBES2016

Adverse fibrin network profile in survivors of brain tumours with established hormonal deficiencies: A potential mechanism for increased vascular risk

Kyriakakis Nikolaos , Kumar Satish S , Oxley Natalie , Phoenix Fladia , Lynch Julie , Ajjan Ramzi , Murray Robert D

Introduction: Long-term survivors of childhood-onset brain tumours have increased risk of premature vascular disease by mechanisms that remain unclear. We hypothesised that a thrombotic fibrin network profile is one mechanism for the increased vascular risk in this population.Methods: We undertook a cross-sectional study in 33 patients with previous history of brain tumours and 33 age and sex-matched healthy controls. We performed clot structure analysis...

ea0044p251 | Thyroid | SFEBES2016

Distribution of free T4 levels in patients with low-risk thyroid cancer on thyroid hormone replacement and pituitary diseases: comparison with the normal population

Seejore Khyatisha , Kyriakakis Nikolaos , Gerrard Georgina , Gill Vanessa , Murray Robert D

Background: Diagnosing secondary hypothyroidism can be challenging, particularly for patients with low-normal free T4 (fT4). Thyroid hormone replacement (THR) in these cases is guided by the normal population fT4 range. The aim of this study was to compare thyroid function tests in thyroid cancer patients on THR and patients with pituitary diseases with or without central hypothyroidism.Methods: We retrospectively collect...

ea0059p205 | Thyroid | SFEBES2018

A second course of antithyroid drug therapy is effective in patients with relapsed Graves’ disease

Seejore Khyatisha , Nawaz Fozia , Kelleher Katherine , Kyaw-Tun Julie , Lynch Julie , Murray Robert D

Background: Antithyroid drugs (ATDs) are preferred as a first-line treatment for Graves’ disease (GD). However, around 50–60% of patients relapse following treatment withdrawal. Radioactive iodine (RAI) or thyroidectomy is recommended for these patients, however, repeat ATD therapy is a further option, dependent upon patient choice. The long-term efficacy of ATD in relapsed GD has not been robustly established.Methods: We conducted a retrospect...

ea0059p207 | Thyroid | SFEBES2018

Can we predict relapse of Graves’ disease after antithyroid drug therapy?

Seejore Khyatisha , Kelleher Katherine , Nawaz Fozia , Kyaw-Tun Julie , Lynch Julie , Murray Robert D

Background: Current therapeutic options for Graves’ disease (GD) include antithyroid drugs (ATD), radioactive iodine (RAI) or thyroidectomy. ATD treatment is widely used but the relatively high recurrence rate (~50%) after ATD discontinuation is a major concern. Identification of risk factors predicting relapse in GD patients after stopping ATD is decisive to guide initial treatment choices.Methods: We conducted a retrospective study to determine th...

ea0038p158 | Neoplasia, cancer and late effects | SFEBES2015

Clot structure analysis in survivors of acute lymphoblastic leukaemia: the role of growth hormone deficiency

Kyriakakis Nikolaos , Kumar Satish S , Lynch Julie , Oxley Natalie , Phoenix Fladia , Ajjan Ramzi , Murray Robert D

Introduction: Childhood-onset cancer survivors demonstrate increased mortality rates due to cardiovascular and cerebrovascular events. Studies suggest that leukaemia and brain tumour survivors have a relative risk of 6.4 and 29.0 respectively for stroke. Adverse lipid profile, body composition, insulin resistance and hypertension have been implicated to the increased cardiovascular risk in these patients, however little is known about procoagulant factors and markers of vascul...

ea0038p326 | Pituitary | SFEBES2015

Impaired quality of life in patients with acromegaly despite long-term disease control: results from a longitudinal study

Kyriakakis Nikolaos , Lynch Julie , O'Dwyer John , Gilbey Stephen G , Murray Robert D

Introduction: Patients with acromegaly are frequently left with long-term adverse sequelae. Cross-sectional evaluation of health-related quality of life (HR-QoL) using both generic and specific questionnaires (AcroQoL) has confirmed HR-QoL to be severely impaired in acromegaly. However, long-term HR-QoL outcomes following disease control have been less well-described.Methods: The disease specific questionnaire AcroQoL and three validated generic question...

ea0037gp.19.03 | Pituitary–Acromegaly | ECE2015

Perceived quality of life in acromegaly: results from a tertiary UK centre

Kyriakakis Nikolaos , Lynch Julie , Gilbey Stephen G , Webb Susan M , Murray Robert D

Introduction: Patients with acromegaly are frequently left with long-term adverse sequelae. When compared with individuals with other pituitary adenomas, patients with acromegaly demonstrate greater impairment in their quality of life (QoL).Methods: The disease-specific questionnaire, AcroQoL, and the generic psychological general well-being schedule (PGWBS) were used to evaluate QoL in an acromegaly patient cohort. Longitudinal data were also collected ...

ea0037ep39 | Adrenal cortex | ECE2015

Clinical management of adrenal insufficiency shows significant heterogeneity: data from the EU-AIR study

Murray Robert D , Ekman Bertil , Jones Beverly A , Marelli Claudio , Quinkler Marcus , Zelissen Pierre

Introduction: No consensus guidelines currently exist as to the optimal glucocorticoid regimen in adrenal insufficiency (AI). In clinical practice physicians utilise a number of different glucocorticoids, usually administered in several doses throughout the day.Methods: The EU-AIR registry is a European multinational, multicentre, prospective, observational study sponsored by Shire inclusive of all patients with AI irrespective of aetiology. We analysed ...

ea0081rc4.3 | Rapid Communications 4: Pituitary and Neuroendocrinology 1 | ECE2022

Pre-treatment GH levels and number of therapeutic interventions for acromegaly management are predictive of altered MRI bone shape and severity of arthropathy in acromegaly

Kyriakakis Nikolaos , Bowes Michael , Lynch Julie , Kingsbury Sarah R , M Orme Steve , Murray Robert D , Conaghan Philip G

Introduction: Emerging research in 3D-bone shape has provided new insights into the pathogenesis of osteoarthritis (OA). OA patients have increased subchondral bone area, associated with higher prevalence of cartilage loss. Higher B-score, a novel, machine learning-derived OA bone biomarker, is associated with increased OA symptom severity and structural progression. Arthropathy, despite being the commonest cause of morbidity amongst acromegaly patients, remains one of the und...